Guidance

Cannabis-based medicines: expert panel

An expert panel of clinicians has been set up to assess applications for special licences to prescribe cannabis-based medicines.

• From: Home Office
• Published: 27 June 2018
• Last updated: 27 September 2018
  Show all updates

  1. 27 September 2018

     Updated dates for when the expert panel will meet to review received licenced applications.

  2. 3 August 2018

     Email for the Expert Panel updated.

  3. 19 July 2018

     Added a paragraph under - Process for considering a license.

  4. 10 July 2018

     Added a link to guidance on the expert panel's ways of working.

  5. 3 July 2018

     Added a link to panel members biographies and disclosures of interest.

  6. 27 June 2018

     First published.

This publication was withdrawn on 26 July 2019

Cannabis-based medicines expert panel no longer exists.

Documents

Cannabis and cannabis-based medicinal products

HTML

Details

The government has announced a review of cannabis-based medicines. During the period of the review, the government will consider licence applications for the use of cannabis-based medicines in exceptional cases where there is an unmet clinical need. This expert panel, made up of clinicians, will advise ministers on any licence applications to prescribe cannabis-based medicines.